Second Line Treatment Options and New Treatments for Metastatic Prostate Cancer

This chapter discusses various treatment options for metastatic castrate resistant prostate cancer, including chemo with Kepazzi-Taxel, immunotherapy with Pembrolycumab, bone strengthening agents, and new targeted therapies.